Company news
KRTL Holding Group, Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
KRTL Biotech Inc. Strengthens Import Operations with Official Customs Broker Appointment, Paving the Way for Global API Expansion
July 30, 2025
KRTL Holding Group Inc. (OTC: KRTL) Bolsters Corporate Leverage with Trademark Recognition and Structural Integration
July 1, 2025
KRTL Biotech Inc. Advances API Supply Chain Strategy with $240,000 Initial Purchase Order
June 11, 2025
KRTL Holding Appoints Dave Orn and Rick Haxton to Accelerate Global Growth at KRTL Biotech Inc.
June 4, 2025
KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative
June 4, 2025
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
April 8, 2025
KRTL Holding Group, Inc Commences Trading on Upstream Under KRTL
April 1, 2025
KRTL Holding Group Reports 2024 Financial Results and Advances Toward International Pharmaceutical Integration
March 31, 2025
KRTL Holding Group, Inc Approved to Dual List on Upstream
March 25, 2025
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 23, 2025
KRTL Biotech Implements MasterControl QMS to Enhance Regulatory Compliance and Pharmaceutical Importation Readiness
March 3, 2025
KRTL Holding Group Inc. Appoints Philip Polito to Board of Directors as Chief Strategy Officer
February 12, 2025
KRTL Holding Group Inc. Appoints Marlen Patricia Wilstermann-Sanzetenea as International Pharmaceutical Sales Director
February 12, 2025
KRTL Holding Group Inc. Welcomes Dr. Marcelo Bascope as Chief International Science Director
February 12, 2025
KRTL Holding Group Expands in Bolivia: A Strategic Leap for Biopharmaceutical Innovation
February 4, 2025
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 21, 2025
KRTL Holding Group Inc. Announces FDA FEI and NDC Certification Achievements by Wholly Owned Subsidiary KRTL Biotech Inc.
January 15, 2025
KRTL Holding Group Inc. (OTC: KRTL) Announces Launch of New KRTL Biotech Website to Streamline Pharmaceutical Industry Solutions
January 7, 2025
KRTL Holding Group Inc. Announces KRTL Biotech Inc. Acquires 55% Majority Stake in Nutrivance Global to Enhance API Distribution and Real-World Data Capabilities
January 7, 2025
KRTL Holding Appoints David Orn to Board of Directors
December 18, 2024
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
December 4, 2024
A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)
November 25, 2024
Earnings release KRTL 9.30.24
November 13, 2024
KRTL Holding Group, Inc Announces Quarterly Financial Report
November 13, 2023
Fostering a Strategic Partnerships to Penetrate Emerging CBD/THC Research Industry in Bolivia
July 17, 2023
KRTL Biotech, Inc. Announces Leadership Transition and Strategic Partnerships
July 17, 2023
KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
May 29, 2023
KRTL International Corp. to Bring Singani to US
May 4, 2023
Cannabis Global and KRTL International Corp. Announce Exclusive Distribution Agreement for Huella Singani
May 1, 2023
KRTL and Yuhan Care Sign MOU to begin the development of CBD Products Between Korea and US
December 13, 2022
KRTL and Yuhan to Begin the Development of Products Between Korea and the US
December 5, 2022
David Beling Appointed Strategic Advisor for KRTL Holdings Group Inc
October 13, 2022
KRTL International Corp. and Cannabis Global Inc. Form Global Strategic Alliance
October 6, 2022
KRTL international and ICANN ventures to launch cannabis education program in Korea
September 23, 2022
KRTL biotech and ENTEXS corporation accelerate alliance at MJBizCon and in South Korea initiatives
September 20, 2022
KRTL to Launch Proprietary Mobile Extraction Technology to Disrupt Cannabis Industry
September 7, 2022
KRTL Holding Group Inc’s Accomplishments and Operational Description
August 22, 2022
KRTL Holding Group Inc Welcomes Dr. Malcolm A. Leissring as Chief Science Officer of KRTL Biotech, Inc.
August 18, 2022
FINRA Approves Name and Ticker Change for KRTL Holding Group, Inc. From QUEENCH, Inc.
July 25, 2022
Here To Serve Holding Corp. Sells Portion of Its Hemp Farming Project for $500,000
July 12, 2022
Correction: KRTL and PERVASIP ANNOUNCE “ARTIZEN WELLNESS” TARGETING THE $1 TRILLION GLOBAL MARKET
July 5, 2022
KRTL and PERVASIP ANNOUNCE “ARTIZEN WELLNESS” TARGETING THE $1 TRILLION GLOBAL MARKET
July 6, 2022
KRTL International Corp. with Artizen Corporation Partner to act as Exclusive Consultants in South Korea
June 28, 2022
KRTL Holding Group Inc Welcomes Daniel Ball as New CEO of KRTL Biotech
June 22, 2022
Queench, Inc. (QENC) provides shareholder update and announces change of control
January 11, 2022